Chauret N - Search Results

1

In Vitro and In Vivo Mechanistic Studies toward Understanding the Role of 1-Aminobenzotriazole in Rat Drug-Drug Interactions.

Boily MO, Chauret N, Laterreur J, Leblond FA, Boudreau C, Duquet MC, Lévesque JF, Ste-Marie L, Pichette V. Boily MO, et al. Among authors: chauret n. Drug Metab Dispos. 2015 Dec;43(12):1960-5. doi: 10.1124/dmd.115.066357. Epub 2015 Oct 5. Drug Metab Dispos. 2015. PMID: 26438628

2

Selective isolation of in vitro phase II conjugates using a lipophilic anionic exchange solid phase extraction method.

Gagné S, Laterreur J, Mahrouche L, Sørensen D, Gauthier JY, Truong VL, Chauret N, Lévesque JF. Gagné S, et al. Among authors: chauret n. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Mar 1;863(2):242-8. doi: 10.1016/j.jchromb.2008.01.032. Epub 2008 Jan 30. J Chromatogr B Analyt Technol Biomed Life Sci. 2008. PMID: 18262477

3

Hypoxia-induced down-regulation of CYP1A1/1A2 and up-regulation of CYP3A6 involves serum mediators.

Fradette C, Bleau AM, Pichette V, Chauret N, Du Souich P. Fradette C, et al. Among authors: chauret n. Br J Pharmacol. 2002 Nov;137(6):881-91. doi: 10.1038/sj.bjp.0704933. Br J Pharmacol. 2002. PMID: 12411420 Free PMC article.

4

Evaluation of human hepatocyte incubation as a new tool for metabolism study of androstenedione and norandrostenedione in a doping control perspective.

Lévesque JF, Gaudreault M, Houle R, Chauret N. Lévesque JF, et al. Among authors: chauret n. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Nov 15;780(1):145-53. doi: 10.1016/s1570-0232(02)00444-0. J Chromatogr B Analyt Technol Biomed Life Sci. 2002. PMID: 12383490

5

In vitro and in vivo biotransformations of the naphthalenic lignan lactone 5-lipoxygenase inhibitor, L-702,539.

Chauret N, Li C, Ducharme Y, Trimble LA, Yergey JA, Ramachandran C, Nicoll-Griffith DA. Chauret N, et al. Drug Metab Dispos. 1995 Jan;23(1):65-71. Drug Metab Dispos. 1995. PMID: 7720527

6

Discovery, biosynthesis, and structure elucidation of new metabolites of norandrostenedione using in vitro systems.

Lévesque JF, Gaudreault M, Aubin Y, Chauret N. Lévesque JF, et al. Among authors: chauret n. Steroids. 2005 Apr;70(4):305-17. doi: 10.1016/j.steroids.2004.12.005. Steroids. 2005. PMID: 15784285

7

Discovery, biosynthesis, and structure elucidation of metabolites of a doping agent and a direct analogue, tetrahydrogestrinone and gestrinone, using human hepatocytes.

Lévesque JF, Templeton E, Trimble L, Berthelette C, Chauret N. Lévesque JF, et al. Among authors: chauret n. Anal Chem. 2005 May 15;77(10):3164-72. doi: 10.1021/ac050150y. Anal Chem. 2005. PMID: 15889905

8

In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse.

Chauret N, Gauthier A, Martin J, Nicoll-Griffith DA. Chauret N, et al. Drug Metab Dispos. 1997 Oct;25(10):1130-6. Drug Metab Dispos. 1997. PMID: 9321515

9

Application of rat hepatocyte culture to predict in vivo metabolic auto-induction: studies with DFP, a cyclooxygenase-2 inhibitor.

Nicoll-Griffith DA, Silva JM, Chauret N, Day S, Leblanc Y, Roy P, Yergey JA, Dixit R, Patrick D. Nicoll-Griffith DA, et al. Among authors: chauret n. Drug Metab Dispos. 2001 Feb;29(2):159-65. Drug Metab Dispos. 2001. PMID: 11159806

10

Use of a benzyloxy-substituted lactone cyclooxygenase-2 inhibitor as a selective fluorescent probe for CYP3A activity in primary cultured rat and human hepatocytes.

Nicoll-Griffith DA, Chauret N, Houle R, Day SH, D'Antoni M, Silva JM. Nicoll-Griffith DA, et al. Among authors: chauret n. Drug Metab Dispos. 2004 Dec;32(12):1509-15. doi: 10.1124/dmd.32.12.. Drug Metab Dispos. 2004. PMID: 15550722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters